Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard B Kim

Showing results (1-10 of 226) with videos related to

Pageof 23
Sort By:
Drug Metabolism Reviews|May 9, 2002
Drugs as P-glycoprotein substrates, inhibitors, and inducersRichard B Kim
Clinical Pharmacology and Therapeutics|September 15, 2019
Precision Medicine: Lessons Learned From Implementation of a Pharmacogenetics-Based Patient Care Program in a Real-World SettingRichard B Kim
Clinical Pharmacology and Therapeutics|April 30, 2004
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) and genetic variability (single nucleotide polymorphisms) in a hepatic drug uptake transporter: what's it all about?Richard B Kim
Molecular Pharmaceutics|May 12, 2006
Transporters and drug discovery: why, when, and howRichard B Kim
Topics in HIV Medicine : a Publication of the International AIDS Society, USA|July 24, 2003
Drug transporters in HIV TherapyRichard B Kim
Pharmacogenetics|August 13, 2002
MDR1 single nucleotide polymorphisms: multiplicity of haplotypes and functional consequencesRichard B Kim
Advanced Drug Delivery Reviews|October 31, 2002
Pharmacogenetics of CYP enzymes and drug transporters: remarkable recent advancesRichard B Kim
Toxicology|December 31, 2002
Transporters and xenobiotic dispositionRichard B Kim
Clinical Pharmacology and Therapeutics|August 9, 2005
Placental transfer of antiretroviral drugsCatia Marzolini, Richard B Kim
Clinical Pharmacology and Therapeutics|May 19, 2025
Deciphering the Relative Contribution of CYP3A4 Versus P-Glycoprotein for the Shared Substrate Cyclosporine-Commentary on Lown et alIngolf Cascorbi, Richard B Kim
Pageof 23

Showing results (1-10 of 226) with videos related to

Sort By:
Pageof 23
Drug Metabolism Reviews|May 9, 2002
Drugs as P-glycoprotein substrates, inhibitors, and inducersRichard B Kim
Clinical Pharmacology and Therapeutics|September 15, 2019
Precision Medicine: Lessons Learned From Implementation of a Pharmacogenetics-Based Patient Care Program in a Real-World SettingRichard B Kim
Clinical Pharmacology and Therapeutics|April 30, 2004
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) and genetic variability (single nucleotide polymorphisms) in a hepatic drug uptake transporter: what's it all about?Richard B Kim
Molecular Pharmaceutics|May 12, 2006
Transporters and drug discovery: why, when, and howRichard B Kim
Topics in HIV Medicine : a Publication of the International AIDS Society, USA|July 24, 2003
Drug transporters in HIV TherapyRichard B Kim
Pharmacogenetics|August 13, 2002
MDR1 single nucleotide polymorphisms: multiplicity of haplotypes and functional consequencesRichard B Kim
Advanced Drug Delivery Reviews|October 31, 2002
Pharmacogenetics of CYP enzymes and drug transporters: remarkable recent advancesRichard B Kim
Toxicology|December 31, 2002
Transporters and xenobiotic dispositionRichard B Kim
Clinical Pharmacology and Therapeutics|August 9, 2005
Placental transfer of antiretroviral drugsCatia Marzolini, Richard B Kim
Clinical Pharmacology and Therapeutics|May 19, 2025
Deciphering the Relative Contribution of CYP3A4 Versus P-Glycoprotein for the Shared Substrate Cyclosporine-Commentary on Lown et alIngolf Cascorbi, Richard B Kim
Pageof 23